Xinshuaining preparation ameliorates doxorubicin-induced cardiac injury in heart failure rats by regulating gut microbiota
Drug Delivery and Translational Research · 2026
DOI: 10.1007/s13346-025-01879-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2026. Verfasst von Qian Nie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital of Chengdu University of Traditional Chinese Medicine, No.39-41, Shierqiao Road, Jinniu District, Chengdu, 610075,…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Doxorubicin, Heart Failure, Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Provincial Unit Traditional Chinese Medicine Development Fund (Center for the Prevention and Treatment of Major Diseases of Traditional Chinese Medicine).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) has a serious impact on patients' lives and health. Gut microbiota plays an important role in the development of HF. Xinshuaining (XSN) preparation has a therapeutic effect on the HF. However, the mechanism of action of XSN in HF is still unclear. Our study aimed to explore the possible function and mechanism of XSN on HF induced by doxorubicin (DOX) in rats. DOX-induced HF rat models were prepared, grouped and treated. The ultrasound indexes of rat heart were measured before sampling, and the indexes of cardiac pathology, fibrosis degree, gut microbiota and metabolites were detected by ELISA, HE staining, Masson staining, immunohistochemistry, 16SrDNA sequencing, liquid chromatography-mass spectrometry (LC/MS) after sampling. XSN can significantly improve the cardiac function of HF rats, including increasing LVEF, LVFS, decreasing LVESD, LVESV, LVEDV levels, and at the same time, XSN can also reduce the heart weight index, reduce the cardiac histopathological damage and fibrosis. In addition, XSN can regulate the abundance and function of gut microbiota, inhibit the level of TMAO, and regulate plasma metabolites in HF rats. In conclusions, XSN improves cardiac function and delays the process of cardiac fibrosis in HF rats, and its mechanism may be related to the regulation of gut microbiota and metabolites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Hospital of Chengdu University of Traditional Chinese Medicine, No.39-41, Shierqiao Road, Jinniu District, Chengdu, 610075, China.
- Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Department of Cardiology, Hospital of Chengdu University of Traditional Chinese Medicine, No.39-41, Shierqiao Road, Jinniu District, Chengdu, 610075, China. Xie18980880217@126.com.
Förderung
- Provincial Unit Traditional Chinese Medicine Development Fund (Center for the Prevention and Treatment of Major Diseases of Traditional Chinese Medicine)
Zitieren
APA
Nie, Q., Zhao, J., Haseeb, S., Deng, S., Zhang, X., Wang, R., Luo, X., & Xie, W. (2026). Xinshuaining preparation ameliorates doxorubicin-induced cardiac injury in heart failure rats by regulating gut microbiota. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-025-01879-9
Vancouver
Nie Q, Zhao J, Haseeb S, Deng S, Zhang X, Wang R, et al. Xinshuaining preparation ameliorates doxorubicin-induced cardiac injury in heart failure rats by regulating gut microbiota. Drug Delivery and Translational Research. 2026. doi:10.1007/s13346-025-01879-9
BibTeX
@article{Nie2026,
author = {Nie, Qian and Zhao, Jue and Haseeb, Sattar and Deng, Siwei and Zhang, Xin and Wang, Rui and Luo, Xu and Xie, Wen},
title = {Xinshuaining preparation ameliorates doxorubicin-induced cardiac injury in heart failure rats by regulating gut microbiota},
journal = {Drug Delivery and Translational Research},
year = {2026},
doi = {10.1007/s13346-025-01879-9}
}
EUVIMED